BackApotea AB Overview
Apotea AB

Apotea AB Return on Equity

Apotea AB (APOTEA.ST) has a ROE of 25.08%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

25.08%

Return on Equity

25.08%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Apotea AB (APOTEA.ST) FAQ

The latest ROE for APOTEA.ST is 25.08%. That is above the sector sector average of 11.3%. Investors often review this figure alongside Apotea AB's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, APOTEA.ST currently prints 25.08% for ROE, while the sector average sits near 11.3%. That is roughly 122.0% above the sector mean. Large gaps often invite a closer look at Apotea AB's growth, margins, and balance sheet.

Return on Equity shows how effectively Apotea AB converts resources into returns. At 25.08%, APOTEA.ST may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting APOTEA.ST's ROE (25.08%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.